Core Insights - Aclarion, Inc. is participating in the 2025 Spine Summit to showcase its innovative NOCISCAN technology aimed at addressing chronic low back pain [1][3] Company Overview - Aclarion is a healthcare technology company that utilizes biomarkers and proprietary augmented intelligence algorithms to assist physicians in identifying chronic low back pain [1][7] - The company’s NOCISCAN platform is the first evidence-supported SaaS solution designed to noninvasively differentiate between painful and nonpainful discs in the lumbar spine [4][7] Technology and Innovation - NOCISCAN combines Magnetic Resonance Spectroscopy (MRS) with augmented intelligence to provide critical insights into the location of low back pain, enabling tailored treatment plans for patients [2][4][8] - The platform quantifies chemical biomarkers associated with disc pain, enhancing diagnostic accuracy when used alongside other tools [4][10] Event Participation - Dr. Nicholas Theodore, a prominent orthopedic surgeon, will present at the Spine Summit, discussing the transformative impact of NOCISCAN on spine surgery [2][9] - The presentation is scheduled for February 21, 2025, at the JW Marriott Tampa Water Street [9]
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit